Oncogenes and tumour suppressor genes Flashcards
The hallmarks of cancer
Sustain proliferative signalling Resisting cell death Angiogenesis Replicative immortality Invasion and metastases Evading growth suppressors Deregulating cellular energetics Genome instability and mutation Avoiding immune destruction Tumour-promoting inflammation
Genetic mutation bladder cancer
KRAS
genetic mutation colon cancer
KRAS
What are oncogenes?
Genes that, under certain circumstances, transform a normal cell into a cancerous cell
How do you activate Ras
GTP- GDP
genetic mutation causing lung cancer
EGFR
Mutations of c-KIT
In juxtamembrane domain = activation of tyrosine kinase in absence of ligand
Mutation stimulates growth of cancer cells
Retinoblastoma o/e
Opacity in eye , present before 8 y/o
Hereditary retinoblastoma
Single mutation = all cells in body contain mutation. If there is a second mutation by chance then there will be increased proliferation
Non-hereditary retinoblastoma
Two mutations in same cell - often only occurs in one eye
Rb gene
- Germline mutation of RB in hereditary retinoblastoma
- Ater restriction point, cell is ‘committed to cell cycle’
- During early G1, RB protein hypo-phosphorylated
- After resurrection, hyperphosphorylation until cytokinesis
- RB binds to E2F transcription factors
- Hyperphosphorylation interferes with binding and releases E2F proteins allowing expression of genes for cell cycle gene
- If both RB mutated, no cell cycle regulation, this removes restriction point
Mechanism of p53
Phosphorylated p53 can not bind to MDM2
Phosphorylated p53 acts as transcription factor
Activates Chi p21
Binds cyclin-CDK complexes (cell cycle arrest)
Missense mutations inhibit p53 from binding to target genes